...
首页> 外文期刊>American Journal of Ophthalmology: The International Journal of Ophthalmology >Prospective head-to-head study comparing 2 commercial interferon gamma release assays for the diagnosis of tuberculous uveitis
【24h】

Prospective head-to-head study comparing 2 commercial interferon gamma release assays for the diagnosis of tuberculous uveitis

机译:头对头研究比较了两种商业性干扰素γ释放试验对结核性葡萄膜炎的诊断

获取原文
获取原文并翻译 | 示例
           

摘要

? Purpose: To perform a head-to-head comparison of 2 commercially available interferon-gamma release assays, QuantiFERON-TB Gold In-Tube (Cellestis, Chadstone, Victoria, Australia) and T-SPOT.TB (Oxford Immunotech, Abingdon, Oxfordshire, UK), in the diagnosis of tuberculous uveitis. ? Design: Prospective cohort to study diagnostic accuracy. ? Methods: We recruited consecutive new patients who presented with uveitis to a tertiary institution over a 2-year period. All patients underwent complete ocular examination and systemic evaluation, including T-SPOT.TB, QuantiFERON-TB Gold In-Tube, and tuberculin skin test. Patients were followed-up for a minimum of 1 year after completion of antituberculous therapy where indicated. The main outcome measures were the sensitivity, specificity and accuracy of each test, estimated using Bayesian latent class analysis (presented with 95% Bayesian credible intervals) (Crl). Prior information was obtained from published meta-Analyses for diagnostic tests: QuantiFERON Gold In-Tube sensitivity (0.64, 0.59-0.69) and specificity (0.99, 0.99-1.00); T-SPOT. tuberculosis sensitivity (0.50, 0.33-0.67) and specificity (0.91, 0.88-0.93). ? Results: From our study in patients with uveitis, QuantiFERON-TB Gold In-Tube was more specific but slightly less sensitive (sensitivity: 0.64, 0.60-0.69; specificity: 0.995, 0.988-0.999) than T-SPOT.TB (sensitivity: 0.67, 0.60-0.74; specificity: 0.91, 0.88-0.93). However, QuantiFERON Gold In-Tube was significantly more accurate in identifying true-positive tuberculous uveitis cases than was T-SPOT.TB among discordant cases (QuantiFERON Gold In-Tube positive 98% vs T-SPOT.TB positive 76%; ratio 1.28, 95% Crl: 1.11-1.72, ie, 95% Crl >1.0, statistically significant). ? Conclusion: Based on statistical decision theory, our head-to-head study suggests that QuantiFERON-TB Gold In-Tube is the first-line test that should be performed in preference to T-SPOT.TB (and the tuberculin skin test) for diagnosing tuberculous uveitis.
机译:?目的:为了进行两种市售干扰素-γ释放测定的正面对比,QuantiFERON-TB金管(Cellestis,Chadstone,澳大利亚维多利亚)和T-SPOT.TB(Oxford Immunotech,牛津,阿宾登) ,英国),用于诊断结核性葡萄膜炎。 ?设计:前瞻性队列研究诊断准确性。 ?方法:我们招募了连续两年在第三级接受葡萄膜炎治疗的新患者。所有患者均接受了完整的眼科检查和全身评估,包括T-SPOT.TB,QuantiFERON-TB金管和结核菌素皮肤测试。必要时,在完成抗结核治疗后对患者进行至少1年的随访。主要结局指标是每次测试的敏感性,特异性和准确性,这些指标使用贝叶斯潜在类别分析(以95%贝叶斯可信区间表示)(Crl)估算。从已发表的用于诊断测试的荟萃分析中获得了先前的信息:QuantiFERON Gold In-Tube敏感性(0.64,0.59-0.69)和特异性(0.99,0.99-1.00); T点结核敏感性(0.50,0.33-0.67)和特异性(0.91,0.88-0.93)。 ?结果:根据我们对葡萄膜炎患者的研究,QuantiFERON-TB金管比T-SPOT.TB(敏感性:0.65,0.60-0.69;特异性:0.995,0.988-0.999)更具特异性,但敏感性略低。 0.67,0.60-0.74;特异性:0.91,0.88-0.93)。但是,在不协调的病例中,QuantiFERON Gold In-Tube在鉴别真阳性结核性葡萄膜炎病例中比T-SPOT.TB准确得多(QuantiFERON Gold In-Tube阳性98%vs T-SPOT.TB阳性76%;比率1.28 ,95%Crl:1.11-1.72,即95%Crl> 1.0,具有统计学意义。 ?结论:基于统计决策理论,我们的直接研究表明,QuantiFERON-TB金管是一线测试,应优先于T-SPOT.TB(和结核菌素皮肤测试)进行。诊断结核性葡萄膜炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号